| 16th November |
Pharmacodynamics of Mycobacterium tuberculosis DNA gyrase inhibitors |
Emmanuel Moyo, PhD Candidate, LSTM |
| 19th October |
Integrating animal and human TB research, policy, and prevention practices |
Dr Camille Bellet, Post-doctoral Research Associate, University of Liverpool |
| 27th September | Why are TB patients with complex needs less likely to complete TB treatment CTID Board room 2-3pm, LSTM |
Jeniffer Mithoo, TB Specialist Nurse and PhD candidate, Liverpool School of Tropical Medicine |
| 27th July | An overview of the national tuberculosis control strategy in England CTID Board room 2-3pm, LSTM |
Dr Paul Cleary, Consultant Epidemiologist Public Health England |
| 22nd June | Not another randomised controlled trial: TB modelling, evidence synthesis, and anecdote CTID Board room 2-3pm, LSTM |
Dr Bhagteshwar Singh, Specialist Registrar in Infection Royal Liverpool Hospital and LSTM |
| 18th May | Long term sequelae of pulmonary TB including the hidden burden of chronic pulmonary aspergillosis CTID Board room 2-3pm, LSTM |
Dr Iain Page, |
| 20th April 2017 |
A career in TB in north west England and the current landscape of TB care and prevention |
Professor Peter Ormerod, Professor of Respiratory Medicine at The Universities of Manchester and Central Lancashire and NICE TB Guideline Development Group |
| 23rd March 2017 |
The role of mathematical modelling in preventing TB transmission |
Dr Thomas House |
| 16 February 2017 |
Improving routine services for chronic cough in primary care in Malawi; the potential effect on TB case finding |
Prof Bertie Squire, LSTM Chair in Clinical Tropical Medicine, Director CAHRD |
| 26th January 2017 | Biomarkers in tuberculosis clinical trials CTID Board room 2-3pm, LSTM |
Dr Gerry Davies, Infectious Diseases Consultant Physician and Reader in Clinical Pharmacology, University of Liverpool |
